INOTEK PHARMACEUTICALS CORP
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for INOTEK PHARMACEUTICALS CORP NOTE 5.750% 8/0, CUSIP 45780VAB8.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for INOTEK PHARMACEUTICALS CORP NOTE 5.750% 8/0, CUSIP 45780VAB8.